Enhancing anti-tumour efficacy with immunotherapy combinations - The Lancet
Current issues and perspectives in PD-1 blockade cancer immunotherapy | SpringerLink
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients - Clinical Lung Cancer
Immunotherapy for cancer: How it works, who's a candidate, and where to get it | CTCA
Epitope spreading is spreading success in immunotherapy
How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer - Annals of Oncology
Profiling of immune features to predict immunotherapy efficacy
Frontiers | Biomarkers in Immunotherapy-Based Precision Treatments of Digestive System Tumors
Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment | npj Precision Oncology
Biomarkers in Cancer Immunotherapy - Cancer Research Institute
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors | Biomarker Research | Full Text
Cancer immunotherapy: Pros, cons and beyond - ScienceDirect
Frontiers | Toward Systems Biomarkers of Response to Immune Checkpoint Blockers
Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds | Science Advances
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
Working towards a safer and more effective oral immunotherapy – a treatment for food allergy – EAACI Patients
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy | Nature Reviews Cancer
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
Frontiers | Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
Overcoming the Resistance to Immunotherapy
Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development - ScienceDirect
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - Pathology
Early Screening of Pancreatic Cancer Immunotherapy Target Candidates | Technology Networks
VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy: Trends in Immunology
Making immunotherapy more effective against small cell lung cancer
Immunotherapy and targeted therapy combinations in metastatic breast cancer - The Lancet Oncology
